{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T04:05:08Z","timestamp":1777349108118,"version":"3.51.4"},"reference-count":16,"publisher":"American Society for Microbiology","issue":"5","license":[{"start":{"date-parts":[[2021,4,19]],"date-time":"2021-04-19T00:00:00Z","timestamp":1618790400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1128\/ASMCopyrightv2"},{"start":{"date-parts":[[2021,4,19]],"date-time":"2021-04-19T00:00:00Z","timestamp":1618790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2021,4,19]]},"abstract":"<jats:p>\n            <jats:named-content content-type=\"genus-species\">Stenotrophomonas maltophilia<\/jats:named-content>\n            is an emerging cause of serious infections with high associated mortality in immunocompromised patients. Treatment of\n            <jats:named-content content-type=\"genus-species\">S. maltophilia<\/jats:named-content>\n            infections is complicated by intrinsic resistance to many antimicrobials, including carbapenems, aminoglycosides, and some cephalosporins.\n          <\/jats:p>","DOI":"10.1128\/aac.02631-20","type":"journal-article","created":{"date-parts":[[2021,2,5]],"date-time":"2021-02-05T14:29:59Z","timestamp":1612535399000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":20,"title":["Evaluation of the Performance of Manual Antimicrobial Susceptibility Testing Methods and Disk Breakpoints for Stenotrophomonas maltophilia"],"prefix":"10.1128","volume":"65","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0489-0712","authenticated-orcid":true,"given":"Ayesha","family":"Khan","sequence":"first","affiliation":[{"name":"Center for Antimicrobial Resistance and Microbial Genomics, University of Texas Health Science Center, Houston, Texas, USA"},{"name":"Division of Infectious Diseases, McGovern Medical School, University of Texas Health Science Center, Houston, Texas, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cedric H.","family":"Pettaway","sequence":"additional","affiliation":[{"name":"Center for Antimicrobial Resistance and Microbial Genomics, University of Texas Health Science Center, Houston, Texas, USA"},{"name":"Division of Infectious Diseases, McGovern Medical School, University of Texas Health Science Center, Houston, Texas, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0524-9473","authenticated-orcid":true,"given":"Jennifer","family":"Dien Bard","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Children\u2019s Hospital of Los Angeles, Los Angeles, California, USA"},{"name":"Keck School of Medicine, University of Southern California, Los Angeles, California, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cesar A.","family":"Arias","sequence":"additional","affiliation":[{"name":"Center for Antimicrobial Resistance and Microbial Genomics, University of Texas Health Science Center, Houston, Texas, USA"},{"name":"Division of Infectious Diseases, McGovern Medical School, University of Texas Health Science Center, Houston, Texas, USA"},{"name":"Center for Infectious Diseases, School of Public Health, University of Texas Health Science Center, Houston, Texas, USA"},{"name":"Molecular Genetics and Antimicrobial Resistance Unit, International Center for Microbial Genomics, Universidad El Bosque, Bogot\u00e1, Colombia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Micah M.","family":"Bhatti","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, MD Anderson Cancer Center, Houston, Texas, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6568-156X","authenticated-orcid":true,"given":"Romney M.","family":"Humphries","sequence":"additional","affiliation":[{"name":"Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofy293"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhin.2012.02.008"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-015-0801-7"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2015.00893"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1086\/522998"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw201"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofx163.563"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01154-19"},{"key":"e_1_3_2_10_2","volume-title":"Performance standards for antimicrobial susceptibility testing. M100 S17.","author":"Clinical and Laboratory Standards Institute","year":"2007","unstructured":"Clinical and Laboratory Standards Institute. 2007. Performance standards for antimicrobial susceptibility testing. M100 S17. Clinical and Laboratory Standards Institute, Wayne, PA."},{"key":"e_1_3_2_11_2","volume-title":"Performance standards for antimicrobial susceptibility testing: CLSI M100 edition 30.","author":"Clinical and Laboratory Standards Institute","year":"2020","unstructured":"Clinical and Laboratory Standards Institute. 2020. Performance standards for antimicrobial susceptibility testing: CLSI M100 edition 30. Clinical and Laboratory Standards Institute, Wayne, PA."},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2011.03752.x"},{"key":"e_1_3_2_13_2","volume-title":"Development of in vitro susceptibility testing criteria and quality control parameters, M23","author":"Clinical and Laboratory Standards Institute","year":"2018","unstructured":"Clinical and Laboratory Standards Institute. 2018. Development of in vitro susceptibility testing criteria and quality control parameters, M23, 5th ed. Clinical and Laboratory Standards Institute, Wayne, PA.","edition":"5"},{"key":"e_1_3_2_14_2","unstructured":"CLSI. 2020. January 2020 meeting methods development and standardization working group report. Clinical and Laboratory Standards Institute Tempe Arizona."},{"key":"e_1_3_2_15_2","volume-title":"Fluoroquinolone breakpoints for Enterobacteriaceae and Pseudomonas aeruginosa. CLSI rationale document MR02.","author":"Chantell C","year":"2019","unstructured":"Chantell C, Humphries RM, Lewis J. 2019. Fluoroquinolone breakpoints for Enterobacteriaceae and Pseudomonas aeruginosa. CLSI rationale document MR02. Clinical and Laboratory Standards Institute, Wayne, PA."},{"key":"e_1_3_2_16_2","unstructured":"FDA. 2020. Antibacterial susceptibility test interpretive criteria. https:\/\/www.fda.gov\/drugs\/development-resources\/antibacterial-susceptibility-test-interpretive-criteria."},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2016.03.004"}],"updated-by":[{"DOI":"10.1128\/aac.00770-21","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2021,5,18]],"date-time":"2021-05-18T00:00:00Z","timestamp":1621296000000}}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.02631-20","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.02631-20","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T21:55:18Z","timestamp":1645480518000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.02631-20"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,19]]},"references-count":16,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,4,19]]}},"alternative-id":["10.1128\/AAC.02631-20"],"URL":"https:\/\/doi.org\/10.1128\/aac.02631-20","relation":{"correction":[{"id-type":"doi","id":"10.1128\/AAC.00770-21","asserted-by":"object"}]},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,19]]},"assertion":[{"value":"2020-12-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-01-29","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-04-19","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e02631-20"}}